Literature DB >> 12791311

Role of interleukin-10 in the induction and function of natural and antigen-induced regulatory T cells.

David C Wraith1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12791311     DOI： 10.1016/s0896-8411(03)00046-5

Source DB:  PubMed          Journal:  J Autoimmun        ISSN： 0896-8411            Impact factor:   7.094


× No keyword cloud information.
  7 in total

Review 1.  Control of experimental autoimmune encephalomyelitis by CD4+ suppressor T cells: peripheral versus in situ immunoregulation.

Authors:  Margaret S Bynoe; Paula Bonorino; Christophe Viret
Journal:  J Neuroimmunol       Date:  2007-09-27       Impact factor: 3.478

2.  IL-10 is essential for disease protection following intranasal peptide administration in the C57BL/6 model of EAE.

Authors:  Emma J O'Neill; Michael J Day; David C Wraith
Journal:  J Neuroimmunol       Date:  2006-07-26       Impact factor: 3.478

3.  IFN-gamma and IL-10 islet-antigen-specific T cell responses in autoantibody-negative first-degree relatives of patients with type 1 diabetes.

Authors:  L G Petrich de Marquesini; J Fu; K J Connor; A J Bishop; N E McLintock; C Pope; F S Wong; C M Dayan
Journal:  Diabetologia       Date:  2010-04-06       Impact factor: 10.122

4.  The effects of tacrolimus ointment on regulatory T lymphocytes in atopic dermatitis.

Authors:  Marzia Caproni; Daniele Torchia; Emiliano Antiga; Walter Volpi; Elena del Bianco; Paolo Fabbri
Journal:  J Clin Immunol       Date:  2006-06-14       Impact factor: 8.317

5.  Proinsulin multi-peptide immunotherapy induces antigen-specific regulatory T cells and limits autoimmunity in a humanized model.

Authors:  V B Gibson; T Nikolic; V Q Pearce; J Demengeot; B O Roep; M Peakman
Journal:  Clin Exp Immunol       Date:  2015-09-17       Impact factor: 4.330

6.  Naturally arising human CD4 T-cells that recognize islet autoantigens and secrete interleukin-10 regulate proinflammatory T-cell responses via linked suppression.

Authors:  Timothy I M Tree; Jennifer Lawson; Hannah Edwards; Ania Skowera; Sefina Arif; Bart O Roep; Mark Peakman
Journal:  Diabetes       Date:  2010-03-18       Impact factor: 9.461

7.  Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study.

Authors:  S L Thrower; L James; W Hall; K M Green; S Arif; J S Allen; C Van-Krinks; B Lozanoska-Ochser; L Marquesini; S Brown; F S Wong; C M Dayan; M Peakman
Journal:  Clin Exp Immunol       Date:  2008-11-20       Impact factor: 4.330
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.